Home › Idiopathic Hypersomnia › Ohio › Cincinnati
Idiopathic Hypersomnia clinical trials in Cincinnati, OH
7 studies for Idiopathic Hypersomnia are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
RecruitingPhase 2/3
- Takeda Site 2, Cincinnati
- Takeda Site 4, Cincinnati
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
RecruitingPhase 3
- Intrepid Research, Cincinnati
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
RecruitingPhase 3
- Intrepid Research, Cincinnati
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2/3
- Alkermes Investigational Site, Cincinnati
- Alkermes Investigational Site, Cincinnati
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
RecruitingPhase 2
- Takeda Site 12, Cincinnati
- Takeda Site 17, Cincinnati
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2
- Cincinnati, Ohio, Cincinnati
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2
- Cincinnati, Ohio, Cincinnati
Idiopathic Hypersomnia trials in other cities
- Charlotte, NC6 studies
- Orlando, FL6 studies
- San Antonio, TX5 studies
- Columbia, SC5 studies
- Austin, TX5 studies
- Miami, FL5 studies
- Atlanta, GA5 studies
- Colorado Springs, CO4 studies
- Brandon, FL4 studies
- Columbus, OH4 studies
- Sterling Heights, MI4 studies
- Philadelphia, PA4 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer35 studies
- Cancer (all types)28 studies
- Breast Cancer25 studies
- Heart Failure24 studies
- Colorectal Cancer21 studies
- Acute Myeloid Leukemia20 studies
- Metastatic Cancer20 studies
- Lung Cancer19 studies
- Obesity19 studies
- Ovarian Cancer19 studies
- Prostate Cancer18 studies
- Melanoma17 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.